Loading…

Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study

Background To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. Methods Fifty-six patients (ages 36 to 85, median 62; 32 fem...

Full description

Saved in:
Bibliographic Details
Published in:European journal of nuclear medicine and molecular imaging 2021-08, Vol.48 (9), p.2914-2924
Main Authors: Casadaban, Leigh C., Catalano, Paul J., Lee, Leslie K., Hyun, Hyewon, Tuncali, Kemal, Gerbaudo, Victor H., Shyn, Paul B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3
cites cdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3
container_end_page 2924
container_issue 9
container_start_page 2914
container_title European journal of nuclear medicine and molecular imaging
container_volume 48
creator Casadaban, Leigh C.
Catalano, Paul J.
Lee, Leslie K.
Hyun, Hyewon
Tuncali, Kemal
Gerbaudo, Victor H.
Shyn, Paul B.
description Background To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. Methods Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT ( n = 77) and postprocedural MRI ( n = 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors. Results Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins < 5 mm. Conclusion Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.
doi_str_mv 10.1007/s00259-021-05206-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2487748862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487748862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</originalsourceid><addsrcrecordid>eNp9kUlPHDEQha2IKCzJH8gBWeKSi6Fsj9t2bmjCEgkpOUzOlru7emjUy8TVjYT483gYAhKHnKoO33u1PMa-SjiVAPaMAJTxApQUYBQUwnxgB7KQXlhwfu-1t7DPDonuAKRTzn9i-1ob461UB-zxnAiJ2mHNY9nFqR0H3se0bgfiY8Mvf1yJeN_WvGvvMfFp7sdEvJ7TVvD7YnW2XIn13NZY8-kWUx-7N5tNGivMKNJ3HnnCKY20wWrKTpymuX74zD42sSP88lKP2J_Li9XyWtz8uvq5PL8RlbZmEt4h2AIr68H6otHGKWOgVAvMN1uHriwboxvbxMK72pWFRV1KA7ZqAKKN-oh92_nmjf7OSFPoW6qw6-KA40xBLZy1C-cKldGTd-jdOKchbxeUWXiQhfYuU2pHVfkkStiETWrz1x6ChLCNJuyiCTma8BxNMFl0_GI9lz3Wr5J_WWRA7wDabN-L6W32f2yfAEjjmZc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2549016398</pqid></control><display><type>article</type><title>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</title><source>Springer Nature</source><creator>Casadaban, Leigh C. ; Catalano, Paul J. ; Lee, Leslie K. ; Hyun, Hyewon ; Tuncali, Kemal ; Gerbaudo, Victor H. ; Shyn, Paul B.</creator><creatorcontrib>Casadaban, Leigh C. ; Catalano, Paul J. ; Lee, Leslie K. ; Hyun, Hyewon ; Tuncali, Kemal ; Gerbaudo, Victor H. ; Shyn, Paul B.</creatorcontrib><description>Background To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. Methods Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT ( n = 77) and postprocedural MRI ( n = 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors. Results Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins &lt; 5 mm. Conclusion Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-021-05206-5</identifier><identifier>PMID: 33559712</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Ablation ; Cardiology ; Computed tomography ; Imaging ; Liver ; Liver cancer ; Magnetic resonance imaging ; Medical imaging ; Medicine ; Medicine &amp; Public Health ; Miscellanea ; Nuclear Medicine ; Oncology ; Original Article ; Orthopedics ; Positron emission ; Positron emission tomography ; Radiology ; Tomography ; Tumors</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2914-2924</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</citedby><cites>FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</cites><orcidid>0000-0003-0538-2151 ; 0000-0002-1105-8852 ; 0000-0003-2466-4787 ; 0000-0002-6132-1700 ; 0000-0002-9060-5489 ; 0000-0001-7388-7253 ; 0000-0002-6252-3427</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33559712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casadaban, Leigh C.</creatorcontrib><creatorcontrib>Catalano, Paul J.</creatorcontrib><creatorcontrib>Lee, Leslie K.</creatorcontrib><creatorcontrib>Hyun, Hyewon</creatorcontrib><creatorcontrib>Tuncali, Kemal</creatorcontrib><creatorcontrib>Gerbaudo, Victor H.</creatorcontrib><creatorcontrib>Shyn, Paul B.</creatorcontrib><title>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Background To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. Methods Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT ( n = 77) and postprocedural MRI ( n = 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors. Results Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins &lt; 5 mm. Conclusion Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.</description><subject>Ablation</subject><subject>Cardiology</subject><subject>Computed tomography</subject><subject>Imaging</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Magnetic resonance imaging</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Miscellanea</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Radiology</subject><subject>Tomography</subject><subject>Tumors</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kUlPHDEQha2IKCzJH8gBWeKSi6Fsj9t2bmjCEgkpOUzOlru7emjUy8TVjYT483gYAhKHnKoO33u1PMa-SjiVAPaMAJTxApQUYBQUwnxgB7KQXlhwfu-1t7DPDonuAKRTzn9i-1ob461UB-zxnAiJ2mHNY9nFqR0H3se0bgfiY8Mvf1yJeN_WvGvvMfFp7sdEvJ7TVvD7YnW2XIn13NZY8-kWUx-7N5tNGivMKNJ3HnnCKY20wWrKTpymuX74zD42sSP88lKP2J_Li9XyWtz8uvq5PL8RlbZmEt4h2AIr68H6otHGKWOgVAvMN1uHriwboxvbxMK72pWFRV1KA7ZqAKKN-oh92_nmjf7OSFPoW6qw6-KA40xBLZy1C-cKldGTd-jdOKchbxeUWXiQhfYuU2pHVfkkStiETWrz1x6ChLCNJuyiCTma8BxNMFl0_GI9lz3Wr5J_WWRA7wDabN-L6W32f2yfAEjjmZc</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Casadaban, Leigh C.</creator><creator>Catalano, Paul J.</creator><creator>Lee, Leslie K.</creator><creator>Hyun, Hyewon</creator><creator>Tuncali, Kemal</creator><creator>Gerbaudo, Victor H.</creator><creator>Shyn, Paul B.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0538-2151</orcidid><orcidid>https://orcid.org/0000-0002-1105-8852</orcidid><orcidid>https://orcid.org/0000-0003-2466-4787</orcidid><orcidid>https://orcid.org/0000-0002-6132-1700</orcidid><orcidid>https://orcid.org/0000-0002-9060-5489</orcidid><orcidid>https://orcid.org/0000-0001-7388-7253</orcidid><orcidid>https://orcid.org/0000-0002-6252-3427</orcidid></search><sort><creationdate>20210801</creationdate><title>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</title><author>Casadaban, Leigh C. ; Catalano, Paul J. ; Lee, Leslie K. ; Hyun, Hyewon ; Tuncali, Kemal ; Gerbaudo, Victor H. ; Shyn, Paul B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Cardiology</topic><topic>Computed tomography</topic><topic>Imaging</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Magnetic resonance imaging</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Miscellanea</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Radiology</topic><topic>Tomography</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casadaban, Leigh C.</creatorcontrib><creatorcontrib>Catalano, Paul J.</creatorcontrib><creatorcontrib>Lee, Leslie K.</creatorcontrib><creatorcontrib>Hyun, Hyewon</creatorcontrib><creatorcontrib>Tuncali, Kemal</creatorcontrib><creatorcontrib>Gerbaudo, Victor H.</creatorcontrib><creatorcontrib>Shyn, Paul B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casadaban, Leigh C.</au><au>Catalano, Paul J.</au><au>Lee, Leslie K.</au><au>Hyun, Hyewon</au><au>Tuncali, Kemal</au><au>Gerbaudo, Victor H.</au><au>Shyn, Paul B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>48</volume><issue>9</issue><spage>2914</spage><epage>2924</epage><pages>2914-2924</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Background To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. Methods Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT ( n = 77) and postprocedural MRI ( n = 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors. Results Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins &lt; 5 mm. Conclusion Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33559712</pmid><doi>10.1007/s00259-021-05206-5</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0538-2151</orcidid><orcidid>https://orcid.org/0000-0002-1105-8852</orcidid><orcidid>https://orcid.org/0000-0003-2466-4787</orcidid><orcidid>https://orcid.org/0000-0002-6132-1700</orcidid><orcidid>https://orcid.org/0000-0002-9060-5489</orcidid><orcidid>https://orcid.org/0000-0001-7388-7253</orcidid><orcidid>https://orcid.org/0000-0002-6252-3427</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1619-7070
ispartof European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2914-2924
issn 1619-7070
1619-7089
language eng
recordid cdi_proquest_miscellaneous_2487748862
source Springer Nature
subjects Ablation
Cardiology
Computed tomography
Imaging
Liver
Liver cancer
Magnetic resonance imaging
Medical imaging
Medicine
Medicine & Public Health
Miscellanea
Nuclear Medicine
Oncology
Original Article
Orthopedics
Positron emission
Positron emission tomography
Radiology
Tomography
Tumors
title Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A40%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20ablation%20margins%20of%20FDG-avid%20liver%20tumors%20during%20PET/CT-guided%20thermal%20ablation%20procedures:%20a%20retrospective%20study&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Casadaban,%20Leigh%20C.&rft.date=2021-08-01&rft.volume=48&rft.issue=9&rft.spage=2914&rft.epage=2924&rft.pages=2914-2924&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-021-05206-5&rft_dat=%3Cproquest_cross%3E2487748862%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2549016398&rft_id=info:pmid/33559712&rfr_iscdi=true